373 results match your criteria: "Okayama City Hospital.[Affiliation]"
J Gastroenterol Hepatol
June 2024
Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.
Background And Aim: The study aims to develop a novel predictive model including the fibrosis (FIB)-3 index for hepatocellular carcinoma (HCC) development in patients with chronic hepatitis C virus (HCV) who achieved sustained virological response (SVR) with direct-acting antiviral (DAA) therapy.
Methods: This study included 2529 patients in whom HCV was eradicated with DAA therapy. The after DAA recommendation for surveillance (ADRES) score, which is based on sex, FIB-4 index, and α-fetoprotein, was used to predict HCC development.
Radiographics
March 2024
From the Department of Radiology (H.T., A.I., T.A.P., N.T.) and Department of Medicine, Division of Rheumatology (Y.S.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; Department of Radiology, Okayama City Hospital, Okayama, Japan (T.T.); Department of Radiology, Jichi Medical University, Tochigi, Japan (S.M.); Department of Diagnostic and Interventional Radiology, University of Tsukuba, Ibaraki, Japan (M.M.); and Department of Radiology, Mayo Clinic, Scottsdale, Ariz (A.K.).
Emerg Med J
February 2024
Rheumatology, Okayama City Hospital, Okayama, Japan.
Sci Rep
January 2024
Department of Neurological Surgery, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
We analyzed the correlation between the duration of electroencephalogram (EEG) recovery and histological outcome in rats in the acute stage of subarachnoid hemorrhage (SAH) to find a new predictor of the subsequent outcome. SAH was induced in eight rats by cisternal blood injection, and the duration of cortical depolarization was measured. EEG power spectrums were given by time frequency analysis, and histology was evaluated.
View Article and Find Full Text PDFSci Rep
January 2024
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Target Oncol
January 2024
Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, via Olgettina 60, 20132, Milan, Italy.
Background: Data concerning the use of lenvatinib in very old patients (≥ 80 years) are limited, although the incidence of hepatocellular carcinoma (HCC) in this patient population is constantly increasing.
Objective: This analysis aimed to evaluate the efficacy and safety of lenvatinib in a large cohort of very old patients (≥ 80 years) with unresectable HCC.
Patients And Methods: The study was conducted on a cohort of 1325 patients from 46 centers in four Western and Eastern countries (Italy, Germany, Japan, and the Republic of Korea) who were undergoing first-line treatment with lenvatinib between July 2010 and February 2022.
J Liver Cancer
March 2024
Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
JAMA Neurol
February 2024
Department of Stroke and Cerebrovascular Medicine, Kyorin University, Mitaka, Japan.
J Gastroenterol Hepatol
April 2024
Department of General Internal Medicine, Okayama City Hospital, Okayama, Japan.
Respir Investig
January 2024
Department of Allergy and Respiratory Medicine, National Hospital Organization, Minami Okayama Medical Center, 4066 Hayashima, Hayashima-cho Tsukubo-gun, Okayama, 701-0304, Japan.
We encountered an extremely rare immunocompetent case of chronic pulmonary aspergillosis (CPA) caused by Aspergillus viridinutans. A 74-year-old woman was admitted with fever and hemoptysis. Chest computed tomography revealed a nodule in the left upper lobe.
View Article and Find Full Text PDFUrol Oncol
March 2024
Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. Electronic address:
Purpose: Radiological tumor burden has been reported to be prognostic in many malignancies in the immunotherapy era, yet whether it is prognostic in patients with metastatic urothelial carcinoma (mUC) treated with pembrolizumab remains uninvestigated. We sought to assess the predictive and prognostic value of radiological tumor burden in patients with mUC.
Methods: We performed a retrospective analysis of 308 patients with mUC treated with pembrolizumab.
Liver Cancer
December 2023
Department of Hepatology, Okayama City Hospital, Okayama, Japan.
Introduction: Because of recent developments in treatments for hepatocellular carcinoma (HCC), methods for determining suitable therapy for initial or recurrent HCC have become important. This study used artificial intelligence (AI) findings to establish a system for predicting prognosis of HCC patients at time of reoccurrence based on clinical data as a reference for selection of treatment modalities.
Methods: As a training cohort, 5,701 observations obtained at the initial and each subsequent treatment for recurrence from 1,985 HCC patients at a single center from 2000 to 2021 were used.
Circ J
June 2024
Department of Internal Medicine, Faculty of Medicine, Kindai University.
Background: In 2016, the DANISH study reported negative results regarding the efficacy of implantable cardioverter-defibrillators (ICDs) in patients with non-ischemic cardiomyopathy (NICM) and reduced left ventricular ejection fraction (LVEF). In this study we determined the efficacy of using ICDs for primary prophylaxis in patients with NICM.
Methods and results: We selected 1,274 patients with underlying cardiac disease who were enrolled in the Nippon Storm Study.
Cureus
October 2023
Department of Orthopedic Surgery, Okayama City Hospital, Okayama, JPN.
Malrotation of tibial fractures after intramedullary nailing remains an unsolved problem. The incidence of malrotation >10° on computer tomography (CT) measurements has been high in cases of tibial shaft fractures. We aimed to assess the accuracy of a novel method for the measurement of tibial rotation using lateral axis views of the C-arm, to prevent postoperative malrotation.
View Article and Find Full Text PDFInt J Cancer
March 2024
Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
Atezolizumab plus bevacizumab (AB) and lenvatinib can be alternatively used as first-line systemic treatment of unresectable hepatocellular carcinoma (HCC). However, no direct comparison of the two regimens has been performed in randomized clinical trials, making the identification of baseline differential predictors of response of major relevance to tailor the best therapeutic option to each patient. Baseline clinical and laboratory characteristics of real-world AB-treated HCC patients were analyzed in uni- and multivariate analyses to find potential prognostic factors of overall survival (OS).
View Article and Find Full Text PDFCancer Med
December 2023
Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan.
Hepatol Res
April 2024
Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan.
Pancreatology
December 2023
Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Okayama, Japan.
Background: EUS-FNA/B for pancreatic ductal adenocarcinoma (PDAC) is generally considered to be safe; however, while the incidence is low, there are occurrences of complications. Among these complications, there are serious ones like needle tract seeding (NTS), and it is not known than which types of tumors have the risks of EUS-FNA/B complications. This study aimed to evaluate the risk of EUS-FNA/B complications in patients with PDAC, focusing on morphological features.
View Article and Find Full Text PDFActa Med Okayama
October 2023
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
To determine the endoscopic and clinical features of localized gastric amyloid light-chain (AL) amyloidosis, we retrospectively examined the characteristics of nine patients (eight men and one woman) encountered by the hospitals in our network. Lesions were predominantly flat and depressed with surface vascular dilatation (n=5); others were characterized by subepithelial lesions (n=2), mucosal color change (n=1), and a mass-like morphology with swollen mucosal folds (n=1). Colonoscopy (n=7), video capsule enteroscopy (n=2), serum (n=5) and urine immunoelectrophoresis (n=4), and bone marrow examination (n=3) were performed to exclude involvement of organs other than the stomach.
View Article and Find Full Text PDFActa Med Okayama
October 2023
Discovery Program for Global Learners, Okayama University.
Using a Collaborative Action Research model, our research team established a one-month clinical resident training program for first- and second-year clinical residents. We created and implemented an assessment rubric to assess the residents' progress toward independent practice in surgery, and thereby, to evaluate the program itself. The program included training in three areas: basic techniques and procedures in the operating room, surgical ward management, and academic activities.
View Article and Find Full Text PDFPLoS One
October 2023
Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Background: Some COVID-19 patients develop life-threatening disease accompanied by severe pneumonitis. Teprenone induces expression of heat-shock proteins (HSPs) that protect against interstitial pneumonia in preclinical models. We explored whether teprenone prevented worsening of COVID-19 infections.
View Article and Find Full Text PDFLiver Int
January 2024
Department of Gastroenterology and Hepatology, Kindai University, Sayama, Osaka, Japan.
Am J Med Sci
February 2024
Department of Surgery, Okayama City Hospital, Okayama, Japan.
Intern Emerg Med
March 2024
Department of Surgery, Okayama City Hospital, Okayama, Japan.
Cancers (Basel)
September 2023
Department of Gastroenterology, Okayama City Hospital, 3-20-1, Kitanagase-omotemachi, Kita-ku, Okayama 700-8557, Japan.
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide and is currently one of the most common cancers [...
View Article and Find Full Text PDF